EFFECTS OF CURRENT THERAPY OF KAWASAKI DISEASE ON EICOSANOID METABOLISM

[1] PATHOLOGY OF KAWASAKI DISEASE .1. PATHOLOGY AND MORPHOGENESIS OF THE VASCULAR CHANGES [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1979, 43 (07): : 633 - 643

[2] BOTHWELL W, 1982, J PHARMACOL EXP THER, V220, P229

[3] INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN [J]. JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) : 314 - 319

[4] COAGULOPATHY AND PLATELET ACTIVATION IN KAWASAKI SYNDROME - IDENTIFICATION OF PATIENTS AT HIGH-RISK FOR DEVELOPMENT OF CORONARY-ARTERY ANEURYSMS [J]. JOURNAL OF PEDIATRICS, 1984, 105 (02) : 206 - 211

[5] BIOCHEMICAL SELECTIVITY OF ORAL VERSUS INTRAVENOUS ASPIRIN IN RATS - INHIBITION BY ORAL ASPIRIN OF CYCLOOXYGENASE ACTIVITY IN PLATELETS AND PRESYSTEMIC BUT NOT SYSTEMIC VESSELS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) : 323 - 326

[6] CARDIAC AND CORONARY ARTERIAL INVOLVEMENT IN INFANTS AND CHILDREN FROM NEW-ENGLAND WITH MUCOCUTANEOUS LYMPH-NODE SYNDROME (KAWASAKI DISEASE) - ANGIOCARDIOGRAPHIC-ECHOCARDIOGRAPHIC CORRELATIONS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (01) : 136 - 142

[7] PHARMACOLOGY OF PLATELET INHIBITION IN HUMANS - IMPLICATIONS OF THE SALICYLATE-ASPIRIN INTERACTION [J]. CIRCULATION, 1985, 72 (06) : 1185 - 1193

[8] TREATMENT OF KAWASAKI SYNDROME [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (06) : 388 - 390

[9] COMPARISON OF MACROSCOPIC, POSTMORTEM, ANGIOGRAPHIC AND TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS OF CORONARY ANEURYSMS IN CHILDREN WITH KAWASAKI-DISEASE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (10) : 761 - 764

[10] FURUSHO K, 1984, LANCET, V2, P1055

[1] PATHOLOGY OF KAWASAKI DISEASE .1. PATHOLOGY AND MORPHOGENESIS OF THE VASCULAR CHANGES [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1979, 43 (07): : 633 - 643

[2] BOTHWELL W, 1982, J PHARMACOL EXP THER, V220, P229

[3] INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN [J]. JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) : 314 - 319

[4] COAGULOPATHY AND PLATELET ACTIVATION IN KAWASAKI SYNDROME - IDENTIFICATION OF PATIENTS AT HIGH-RISK FOR DEVELOPMENT OF CORONARY-ARTERY ANEURYSMS [J]. JOURNAL OF PEDIATRICS, 1984, 105 (02) : 206 - 211

[5] BIOCHEMICAL SELECTIVITY OF ORAL VERSUS INTRAVENOUS ASPIRIN IN RATS - INHIBITION BY ORAL ASPIRIN OF CYCLOOXYGENASE ACTIVITY IN PLATELETS AND PRESYSTEMIC BUT NOT SYSTEMIC VESSELS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) : 323 - 326

[6] CARDIAC AND CORONARY ARTERIAL INVOLVEMENT IN INFANTS AND CHILDREN FROM NEW-ENGLAND WITH MUCOCUTANEOUS LYMPH-NODE SYNDROME (KAWASAKI DISEASE) - ANGIOCARDIOGRAPHIC-ECHOCARDIOGRAPHIC CORRELATIONS [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (01) : 136 - 142

[7] PHARMACOLOGY OF PLATELET INHIBITION IN HUMANS - IMPLICATIONS OF THE SALICYLATE-ASPIRIN INTERACTION [J]. CIRCULATION, 1985, 72 (06) : 1185 - 1193

[8] TREATMENT OF KAWASAKI SYNDROME [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (06) : 388 - 390

[9] COMPARISON OF MACROSCOPIC, POSTMORTEM, ANGIOGRAPHIC AND TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS OF CORONARY ANEURYSMS IN CHILDREN WITH KAWASAKI-DISEASE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (10) : 761 - 764

[10] FURUSHO K, 1984, LANCET, V2, P1055